跳至主要内容
临床试验/NCT00052481
NCT00052481已完成不适用

Health-Related Quality Of Life In Patients With Low Risk, Localized Prostate Cancer Randomized To Radical Prostatectomy Or Brachytherapy

Alliance for Clinical Trials in Oncology13 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2002年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
13
主要终点
time to treatment failure

研究概览

简要总结

RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy.

PURPOSE: Randomized clinical trial to study quality of life in patients undergoing radical prostatectomy or brachytherapy for stage II prostate cancer.

详细描述

OBJECTIVES:

  • Compare changes in health-related quality of life (HRQOL) in patients with stage II prostate cancer up to 2 years after treatment with radical prostatectomy or brachytherapy.
  • Compare the effect of baseline HRQOL, age, and other covariates on HRQOL improvement or deterioration in these patients up to 10 years after these treatments.
  • Compare the effect of treatment modality on HRQOL improvement or deterioration in these patients up to 10 years after these treatments.
  • Compare the effects of treatment failure on HRQOL, in terms of disease progression, in these patients.

OUTLINE: Patients are randomized to 1 of 2 arms on ACOSOG-Z0070 (radical prostatectomy vs brachytherapy).

Patients in both arms complete a quality of life questionnaire at baseline, 2 and 6 months after treatment, and then at 1, 2, 4, 7, and 10 years after treatment.

PROJECTED ACCRUAL: A total of 500 patients (250 per group) will be accrued for this study within 2 years.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

time to treatment failure

时间窗: Up to 10 years

次要结局

  • disease progression(Up to 10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验